Jeffrey H. Buchalter
2009
In 2009, Jeffrey H. Buchalter earned a total compensation of $1.3M as Former President and Chief Executive Officer at Enzon Pharmaceuticals, a 67% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $375,000 |
|---|---|
| Salary | $855,000 |
| Other | $98,267 |
| Total | $1,328,268 |
Buchalter received $855K in salary, accounting for 64% of the total pay in 2009.
Buchalter also received $375K in non-equity incentive plan and $98.3K in other compensation.
Rankings
In 2009, Jeffrey H. Buchalter's compensation ranked 3,547th out of 9,885 executives tracked by ExecPay. In other words, Buchalter earned more than 64.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,547 out of 9,885 | 64th |
Division Manufacturing | 1,238 out of 3,690 | 66th |
Major group Chemicals And Allied Products | 242 out of 866 | 72nd |
Industry group Drugs | 141 out of 638 | 78th |
Industry Biological Products, Except Diagnostic Substances | 23 out of 133 | 83rd |
Source: SEC filing on April 8, 2011.
Buchalter's colleagues
We found five more compensation records of executives who worked with Jeffrey H. Buchalter at Enzon Pharmaceuticals in 2009.
2009
Ivan Horak
Enzon Pharmaceuticals
Chief Scientific Officer
2009
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2009
Ralph del Campo
Enzon Pharmaceuticals
Chief Operating Officer
2009
Paul Davit
Enzon Pharmaceuticals
Executive Vice President, Human Resources and Administration
2009
Mark Ogden
Enzon Pharmaceuticals